Advance your academic career, collaborate globally, and expand your network— join now !

Share Link

Share

Information

José António Belo is a full professor of cellular and molecular biology at NOVA Medical School/Universidade NOVA de Lisboa (NMS/UNL) where, since 2013, he has served as the Director of the Ph.D. Program "ProRegeM". He teaches and is the course director of molecular and cellular biology, developmental biology, stem cells and development, and new cellular and molecular therapies. He is a principal investigator and head of the Stem Cells and Development Lab. Currently, he focuses his studies on the induction and control of myocardium and coronary vasculature development, organogenesis, and function. The Belo lab has been using the most up-to-date technologies in molecular embryology and regenerative medicine, including the generation and analysis of KO mouse lines, mouse and human ES/iPS cell differentiation, and CRISPR/CAS9 technologies. They aim to understand the etiology and treatment of cardiovascular disease from a developmental biology, genetics, and physiology perspective with regenerative medicine purposes.

Short Biography

José António Belo is a full professor of cellular and molecular biology at NOVA Medical School/Universidade NOVA de Lisboa (NMS/UNL) where, since 2013, he has served as the Director of the Ph.D. Program "ProRegeM". He teaches and is the course director of molecular and cellular biology, developmental biology, stem cells and development, and new cellular and molecular therapies. He is a principal investigator and head of the Stem Cells and Development Lab. Currently, he focuses his studies on the induction and control of myocardium and coronary vasculature development, organogenesis, and function. The Belo lab has been using the most up-to-date technologies in molecular embryology and regenerative medicine, including the generation and analysis of KO mouse lines, mouse and human ES/iPS cell differentiation, and CRISPR/CAS9 technologies. They aim to understand the etiology and treatment of cardiovascular disease from a developmental biology, genetics, and physiology perspective with regenerative medicine purposes.